Neurotransmitter transporters (NT-S) have fundamental importance for many physiological processes of neurotransmission, and especially in the mechanisms of drug addiction and abuse. The NT-s to be studied in this Program Project Grant (PPG) are the transporters for dopamine (DT), serotonin (SERT), norepinephrine (NET), and GABA (GAT). Together, they are major molecular targets responsible. for rewarding properties and abuse potential of the most widely used illicit drugs (e.g., cocaine and amphetamine derivatives such as MDMA), and they also play a central role in mechanisms of depression and anxiety. This motivates the multi- disciplinary PPG proposal which addresses in the combined and coordinated approach of six component Projects, the functional richness of the NT-s, their structural underpinnings, and the structure-activity (S-A) basis for the variety of effects elicited by substrates and ligands. The approaches rest on a molecular perspective and a structural context that are only now emerging slowly for NT-s. A synergistic construct of the research plan of the PPG ensures that findings and inferences about structure and function emerging from the study of one NT system in one of the Projects will be directly compared and tested in another. This is stimulated and facilitated by the sharing structural context provided by the molecular models from Project 1. Functional probing with electrophysiological, pharmacological and biochemical methods in Projects 2-6, aims to explore the dynamics mechanisms of the systems. The related structural probing of the NT-s and complexes with ligands will link experimental approaches (including chemical modification, the 3,4,6 with comprehensive computational modeling, structure analysis and prediction, and dynamics simulation in Project 1. Special attention to ligand S-A considerations will be given in Projects 1 and 2, and the results will guide choices of ligands and systems in the other Projects. The combined focus of the PPG is to organize the insights from experiment and computation into a mechanistic understanding of the relation between the molecular architecture of NT-s, and their biological functions. This will be supported by inter-Project collaborations, shared Core activities, and new shared resources. The expected insights concerning the considerations of novel pharmacological interventions for treatment and prevention of psychostimulant abuse.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Program Projects (P01)
Project #
1P01DA012408-01
Application #
2823212
Study Section
Special Emphasis Panel (ZDA1-RXL-E (11))
Program Officer
Hillery, Paul
Project Start
1999-07-09
Project End
2004-06-30
Budget Start
1999-07-09
Budget End
2000-06-30
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Mount Sinai School of Medicine
Department
Physiology
Type
Schools of Medicine
DUNS #
114400633
City
New York
State
NY
Country
United States
Zip Code
10029
Mayer, Felix P; Schmid, Diethart; Owens, W Anthony et al. (2018) An unsuspected role for organic cation transporter 3 in the actions of amphetamine. Neuropsychopharmacology 43:2408-2417
Quick, Matthias; Abramyan, Ara M; Wiriyasermkul, Pattama et al. (2018) The LeuT-fold neurotransmitter:sodium symporter MhsT has two substrate sites. Proc Natl Acad Sci U S A 115:E7924-E7931
Herborg, Freja; Andreassen, Thorvald F; Berlin, Frida et al. (2018) Neuropsychiatric disease-associated genetic variants of the dopamine transporter display heterogeneous molecular phenotypes. J Biol Chem 293:7250-7262
Razavi, Asghar M; Khelashvili, George; Weinstein, Harel (2018) How structural elements evolving from bacterial to human SLC6 transporters enabled new functional properties. BMC Biol 16:31
Doktorova, Milka; Weinstein, Harel (2018) Accurate In Silico Modeling of Asymmetric Bilayers Based on Biophysical Principles. Biophys J 115:1638-1643
LeVine, Michael V; Cuendet, Michel A; Razavi, Asghar M et al. (2018) Thermodynamic Coupling Function Analysis of Allosteric Mechanisms in the Human Dopamine Transporter. Biophys J 114:10-14
Wragg, Rachel T; Parisotto, Daniel A; Li, Zhenlong et al. (2017) Evolutionary Divergence of the C-terminal Domain of Complexin Accounts for Functional Disparities between Vertebrate and Invertebrate Complexins. Front Mol Neurosci 10:146
Doktorova, M; Harries, D; Khelashvili, G (2017) Determination of bending rigidity and tilt modulus of lipid membranes from real-space fluctuation analysis of molecular dynamics simulations. Phys Chem Chem Phys 19:16806-16818
Runegaard, Annika H; Jensen, Kathrine L; Fitzpatrick, CiarĂ¡n M et al. (2017) Preserved dopaminergic homeostasis and dopamine-related behaviour in hemizygous TH-Cre mice. Eur J Neurosci 45:121-128
Jensen, Kathrine L; Runegaard, Annika H; Weikop, Pia et al. (2017) Assessment of Dopaminergic Homeostasis in Mice by Use of High-performance Liquid Chromatography Analysis and Synaptosomal Dopamine Uptake. J Vis Exp :

Showing the most recent 10 out of 146 publications